These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 30504713

  • 1. The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy.
    Gao P, Xu B, Song P, Zhu X, Yuan S, Kanwar YS, Sun L.
    Kidney Blood Press Res; 2018; 43(6):1772-1785. PubMed ID: 30504713
    [Abstract] [Full Text] [Related]

  • 2. myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY.
    Sun L, Dutta RK, Xie P, Kanwar YS.
    J Biol Chem; 2016 Mar 11; 291(11):5688-5707. PubMed ID: 26792859
    [Abstract] [Full Text] [Related]

  • 3. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.
    Sharma I, Tupe RS, Wallner AK, Kanwar YS.
    Am J Physiol Renal Physiol; 2018 Jan 01; 314(1):F107-F121. PubMed ID: 28931523
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy.
    Lu Y, Liu C, Miao X, Xu K, Wu X, Liu C.
    Exp Clin Endocrinol Diabetes; 2009 Jun 01; 117(6):257-65. PubMed ID: 19053028
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.
    Tominaga T, Dutta RK, Joladarashi D, Doi T, Reddy JK, Kanwar YS.
    J Biol Chem; 2016 Jan 15; 291(3):1348-67. PubMed ID: 26578517
    [Abstract] [Full Text] [Related]

  • 6. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.
    Zhan M, Usman IM, Sun L, Kanwar YS.
    J Am Soc Nephrol; 2015 Jun 15; 26(6):1304-21. PubMed ID: 25270067
    [Abstract] [Full Text] [Related]

  • 7. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z, Xu Y, Liu X, Nie Y, Zhao Z.
    Nephrology (Carlton); 2017 Jan 15; 22(1):58-64. PubMed ID: 26733347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Kim WJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK.
    Diabetes Metab Res Rev; 2014 Nov 15; 30(8):736-41. PubMed ID: 24687388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.
    Xie P, Sun L, Oates PJ, Srivastava SK, Kanwar YS.
    Am J Physiol Renal Physiol; 2010 Jun 15; 298(6):F1393-404. PubMed ID: 20335317
    [Abstract] [Full Text] [Related]

  • 15. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
    Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O.
    PLoS One; 2015 Jun 15; 10(4):e0124055. PubMed ID: 25884625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W, Wang J, Ge L, Shan J, Zhang C, Liu J.
    Clin Exp Hypertens; 2017 Jun 15; 39(4):382-387. PubMed ID: 28513288
    [Abstract] [Full Text] [Related]

  • 18. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T, Hadi NR, Abdulameer R, Jamil DA, Al-Aubaidy HA.
    Diabetes Metab Syndr; 2019 Jun 15; 13(1):564-568. PubMed ID: 30641767
    [Abstract] [Full Text] [Related]

  • 19. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients.
    Abd El Dayem S, El Bohy Ael M, El Shehaby A.
    J Pediatr Endocrinol Metab; 2016 Mar 15; 29(3):273-9. PubMed ID: 26677884
    [Abstract] [Full Text] [Related]

  • 20. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY.
    Diabetes Metab Res Rev; 2015 Oct 15; 31(7):717-24. PubMed ID: 25952368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.